Correlation Between Axsome Therapeutics and TG Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Axsome Therapeutics and TG Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Axsome Therapeutics and TG Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Axsome Therapeutics and TG Therapeutics, you can compare the effects of market volatilities on Axsome Therapeutics and TG Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Axsome Therapeutics with a short position of TG Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Axsome Therapeutics and TG Therapeutics.

Diversification Opportunities for Axsome Therapeutics and TG Therapeutics

0.72
  Correlation Coefficient

Poor diversification

The 3 months correlation between Axsome and TGTX is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Axsome Therapeutics and TG Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TG Therapeutics and Axsome Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Axsome Therapeutics are associated (or correlated) with TG Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TG Therapeutics has no effect on the direction of Axsome Therapeutics i.e., Axsome Therapeutics and TG Therapeutics go up and down completely randomly.

Pair Corralation between Axsome Therapeutics and TG Therapeutics

Given the investment horizon of 90 days Axsome Therapeutics is expected to under-perform the TG Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Axsome Therapeutics is 1.69 times less risky than TG Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The TG Therapeutics is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  2,383  in TG Therapeutics on September 27, 2024 and sell it today you would earn a total of  833.00  from holding TG Therapeutics or generate 34.96% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy98.44%
ValuesDaily Returns

Axsome Therapeutics  vs.  TG Therapeutics

 Performance 
       Timeline  
Axsome Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Axsome Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Axsome Therapeutics is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
TG Therapeutics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in TG Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, TG Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Axsome Therapeutics and TG Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Axsome Therapeutics and TG Therapeutics

The main advantage of trading using opposite Axsome Therapeutics and TG Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Axsome Therapeutics position performs unexpectedly, TG Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TG Therapeutics will offset losses from the drop in TG Therapeutics' long position.
The idea behind Axsome Therapeutics and TG Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Content Syndication
Quickly integrate customizable finance content to your own investment portal